Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors

31 Oct 2019

Abstract excerpt

Background: Bladder urothelial cancer (BLCA) treatment using immune checkpoint inhibitors (IMCIs) can result in long-lasting clinical benefits. However, only a fraction of patients respond to such treatment. In this study, we aimed to identify the relationships between immune cell infiltration levels (ICILs) and IMCIs and identify markers for ICILs. Methods: ICILs were estimated based on single-sample gene set...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31737562
DOI: 10.3389/fonc.2019.01101

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint InhibitorsPMID 31737562Read ↗

Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene SetsSemantic proximity Read ↗

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)Semantic proximity Read ↗

Analysis of tumor microenvironment characteristics in bladder cancer: implications for immune checkpoint inhibitor therapySemantic proximity Read ↗

Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity Read ↗

Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.Semantic proximity Read ↗

The Immunogenomic Landscape of and Immune Cell Infiltration in Bladder CancerSemantic proximity Read ↗

Screening and Identifying Immune-Related Cells and Genes in the Tumor Microenvironment of Bladder Urothelial Carcinoma: Based on TCGA Database and BioinformaticsSemantic proximity Read ↗

The Immune Cell Infiltration Patterns and Characterization Score in Bladder Cancer to Identify Prognostic.Semantic proximity Read ↗

A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell GenesSemantic proximity Read ↗

Three Conserved Immune Dysfunction and Exclusion Subtypes in Bladder and Pan-cancers: Prognostic and Immunotherapeutic SignificanceSemantic proximity Read ↗

Prognostic implications of a four-gene signature in non-muscle invasive bladder cancerSemantic proximity Read ↗

An immune cell infiltration-related gene signature predicts prognosis for bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.